GB1361442A - Benzonaphthyridine derivatives - Google Patents

Benzonaphthyridine derivatives

Info

Publication number
GB1361442A
GB1361442A GB5092573A GB5092573A GB1361442A GB 1361442 A GB1361442 A GB 1361442A GB 5092573 A GB5092573 A GB 5092573A GB 5092573 A GB5092573 A GB 5092573A GB 1361442 A GB1361442 A GB 1361442A
Authority
GB
United Kingdom
Prior art keywords
benzo
naphthyridine
dimethoxy
methyl
prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5092573A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB1361442A publication Critical patent/GB1361442A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4

Abstract

1361442 Benzo-naphthyridines SANDOZ Ltd 10 May 1971 [13 May 1970 (2)] 50925/73 Divided out of 1361441 Heading C2C The novel compounds cis-1,2,3,4,4a, 10bhexahydro - 8,9 - dimethoxy - 2 - methyl - 6- phenyl - benzo[c][1,6]naphthyridine and cis-6- (4 - acetamidophenyl) - 1,2,3,4,4a,10b - hexahydro - 8,9 - dimethoxy - 2 - methyl - benzo- [c][1,6]naphthyridine and salts thereof may be prepared by methods disclosed in the parent Specification 1,361,441. Intermediates are prepared as indicated in the parent Specification 1,361,441. Pharmaceutical compositions of the above compounds inhibit blood platelet aggregration when administered with a diluent or carrier.
GB5092573A 1970-05-13 1971-05-10 Benzonaphthyridine derivatives Expired GB1361442A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH708670A CH527196A (en) 1970-05-13 1970-05-13 Process for the preparation of new benzonaphthyridine derivatives

Publications (1)

Publication Number Publication Date
GB1361442A true GB1361442A (en) 1974-07-24

Family

ID=4319709

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5092573A Expired GB1361442A (en) 1970-05-13 1971-05-10 Benzonaphthyridine derivatives

Country Status (3)

Country Link
BE (1) BE767031A (en)
CH (1) CH527196A (en)
GB (1) GB1361442A (en)

Also Published As

Publication number Publication date
CH527196A (en) 1972-08-31
BE767031A (en) 1971-10-01

Similar Documents

Publication Publication Date Title
IE36947B1 (en) New esters their production and their medicinal use
GB1393521A (en) Berberine derivatives and their use in pharmaceutical compositions
GB1147379A (en) 4-alkyl-dialkoxy-ª‡-methylphenethylamines and pharmacologically acceptable salts
GB1268951A (en) Phenoxy-amines
GB1436080A (en) Ellipticine derivative and pharmaceutical uses thereof
GB1261147A (en) Pentanedione derivatives
GB1362845A (en) Benzyl alcohol derivatives
GB1361442A (en) Benzonaphthyridine derivatives
GB1421385A (en) Polyvinyl chloride compositions
IE34590L (en) Phenylethanolamine derivatives
GB1449404A (en) N-arylsulphonyl urea derivatives
IE34081B1 (en) Butanolamine derivatives
GB1424348A (en) Isoquinoline derivatives
GB1290300A (en)
GB1468079A (en) Ethanolamine derivatives
GB1302353A (en)
GB1266890A (en)
GB1278368A (en) Hydroxy-2-piperidinyl carbinols
GB1169990A (en) Phenoxy Propan-2-Olamines
IE39401B1 (en) New adrenergic blocking aminopropanols
GB1275875A (en) 3-amino-2-(3,4-disubstituted)bicyclo(2.2.2)octan-2-ols
GB1340535A (en) Benzodiazepine derivatives
GB1461558A (en) Spasmium salt
GB1298619A (en) Thieno benzopyran and thiopyrano benzopyran derivatives and method of making the same
GB1310779A (en) N-pyridylalkyl-beta-alkoxy-beta-trifluoromethylphenalkylamines

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee